XML 38 R28.htm IDEA: XBRL DOCUMENT v3.24.3
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Mar. 25, 2024
Feb. 12, 2024
Jan. 08, 2024
Sep. 30, 2024
Jun. 30, 2024
Sep. 30, 2023
Mar. 31, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Number of options outstanding       1,959,741       1,959,741        
Number of options outstanding       1,953,491       1,953,491     1,357,466  
Share based compensation weighted average exercise price       $ 5.36       $ 5.36        
Share based compensation intrinsic value       $ 0       $ 0        
Options to purchase common stock               742,150        
Options vested shares               164,412        
Employees [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Share based compensation expense       61,765   $ 1,713   $ 124,359 $ 5,140      
Unamortized stock option expense       595,816       595,816        
Non-Employees [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Share based compensation expense       188,638   $ 164,994   553,344 $ 494,981      
Unamortized stock option expense       $ 666,134       $ 666,134        
Share-Based Payment Arrangement, Option [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Number of options issued       0   0   742,150 0      
Number of options outstanding       1,953,491       1,953,491     1,357,466  
Share based compensation weighted average exercise price       $ 5.36       $ 5.36     $ 7.39  
Share based compensation expense       $ 250,403   $ 166,707   $ 677,703 $ 500,121      
Unamortized stock option expense       1,261,950       $ 1,261,950        
Weighted average period for unamortized stock compensation (in years)               2 years 10 months 9 days        
Options to purchase common stock               742,150        
Options exercise price               $ 1.73        
Share-Based Payment Arrangement, Option [Member] | General and Administrative Expense [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Share based compensation expense       124,570   51,526   $ 308,025 154,578      
Share-Based Payment Arrangement, Option [Member] | Research and Development Expense [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Share based compensation expense       $ 125,833   115,181   $ 369,678 $ 345,543      
2016 Plan [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Number of additional shares granted                     186,594 184,260
Number of shares available for grant       873,763       873,763     1,279,181  
2016 Plan [Member] | Forecast [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Number of additional shares granted                   196,857    
Common Stock [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Number of shares issued for cash       337,681 32,134     361,490        
Number of shares issued for reverse stock splits             9,644   9,644      
Common Stock [Member] | Consulting Agreement [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Options to purchase common stock   4,400                    
Options expire period   10 years                    
Options vest period   3 months                    
Monthly payment   $ 5,000                    
Options exercise price   $ 5.00                    
Common Stock [Member] | Employees and Consultants [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Options to purchase common stock     20,750                  
Options exercise price     $ 0.84                  
Options expire period     10 years                  
Options vest period     48 months                  
Common Stock [Member] | Officers, Board of Directors and Consultants [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Options to purchase common stock 717,000                      
Options exercise price $ 1.74                      
Options expire period 10 years                      
Options vested shares 160,000                      
Common Stock [Member] | Officers, Board of Directors and Consultants [Member] | Minimum [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Options vest period 24 months                      
Common Stock [Member] | Officers, Board of Directors and Consultants [Member] | Maximum [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Options vest period 48 months                      
Warrant [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Share based compensation expense       $ 0   $ 0   $ 0 $ 0      
Warrant shares, outstanding       942,566       942,566     942,566  
Warrant exercise price       $ 19.47       $ 19.47        
Class of warrant or right, outstanding, intrinsic value       $ 0       $ 0